Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)

HFA Vasen, G Möslein, A Alonso, I Bernstein… - Journal of medical …, 2007 - jmg.bmj.com
Lynch syndrome (hereditary non-polyposis colorectal cancer) is characterised by the
development of colorectal cancer, endometrial cancer and various other cancers, and is …

[PDF][PDF] Comprehensive mutation analysis of TSC1 and TSC2—and phenotypic correlations in 150 families with tuberous sclerosis

AC Jones, MM Shyamsundar, MW Thomas… - The American Journal of …, 1999 - cell.com
Tuberous sclerosis (TSC [MIM 191090 and MIM 191100]) is an autosomal dominant
disorder characterized by hamartomas in many organs. Two thirds of cases are sporadic …

Tuberous sclerosis complex

EP Henske, S Jóźwiak, JC Kingswood… - Nature reviews Disease …, 2016 - nature.com
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder that affects multiple
organ systems and is caused by loss-of-function mutations in one of two genes: TSC1 or …

Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34

M Slegtenhorst, R Hoogt, C Hermans, M Nellist… - Science, 1997 - science.org
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by the
widespread development of distinctive tumors termed hamartomas. TSC-determining loci …

Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors

N Al-Tassan, NH Chmiel, J Maynard, N Fleming… - Nature …, 2002 - nature.com
Inherited defects of base excision repair have not been associated with any human genetic
disorder, although mutations of the genes mutM and mutY, which function in Escherichia coli …

[HTML][HTML] Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations

H Northrup, ME Aronow, EM Bebin, J Bissler… - Pediatric Neurology, 2021 - Elsevier
Background Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disease
affecting multiple body systems with wide variability in presentation. In 2013, Pediatric …

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

HFA Vasen, I Blanco, K Aktan-Collan, JP Gopie… - Gut, 2013 - gut.bmj.com
Lynch syndrome (LS) is characterised by the development of colorectal cancer, endometrial
cancer and various other cancers, and is caused by a mutation in one of the mismatch repair …

[BOOK][B] Tuberous sclerosis complex

MR Gomez, JR Sampson, VH Whittemore - 1999 - books.google.com
Tuberous Sclerosis is a genetic disease characterized by lesions of the skin and central
nervous system, seizures, and sometimes sever mental retardation. Infants with this disease …

Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database

P Møller, TT Seppälä, I Bernstein, E Holinski-Feder… - Gut, 2018 - gut.bmj.com
Background Most patients with path_MMR gene variants (Lynch syndrome (LS)) now
survive both their first and subsequent cancers, resulting in a growing number of older …

[HTML][HTML] Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

M Dominguez-Valentin, JR Sampson, TT Seppälä… - Genetics in …, 2020 - nature.com
Purpose Pathogenic variants affecting MLH1, MSH2, MSH6, and PMS2 cause Lynch
syndrome and result in different but imprecisely known cancer risks. This study aimed to …